197 related articles for article (PubMed ID: 33326089)
1. Germline Variation and Somatic Alterations in Ewing Sarcoma.
Machiela MJ; Grünewald TGP
Methods Mol Biol; 2021; 2226():3-14. PubMed ID: 33326089
[TBL] [Abstract][Full Text] [Related]
2. Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite.
Grünewald TG; Bernard V; Gilardi-Hebenstreit P; Raynal V; Surdez D; Aynaud MM; Mirabeau O; Cidre-Aranaz F; Tirode F; Zaidi S; Perot G; Jonker AH; Lucchesi C; Le Deley MC; Oberlin O; Marec-Bérard P; Véron AS; Reynaud S; Lapouble E; Boeva V; Rio Frio T; Alonso J; Bhatia S; Pierron G; Cancel-Tassin G; Cussenot O; Cox DG; Morton LM; Machiela MJ; Chanock SJ; Charnay P; Delattre O
Nat Genet; 2015 Sep; 47(9):1073-8. PubMed ID: 26214589
[TBL] [Abstract][Full Text] [Related]
3. Linking germline and somatic variation in Ewing sarcoma.
Gomez NC; Davis IJ
Nat Genet; 2015 Sep; 47(9):964-5. PubMed ID: 26313223
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of polymorphisms in EWSR1 and risk of Ewing sarcoma: a report from the Childhood Cancer Survivor Study.
DuBois SG; Goldsby R; Segal M; Woo J; Copren K; Kane JP; Pullinger CR; Matthay KK; Witte J; Lessnick SL; Robison LL; Bhatia S; Strong LC
Pediatr Blood Cancer; 2012 Jul; 59(1):52-6. PubMed ID: 21793187
[TBL] [Abstract][Full Text] [Related]
5. Proteasomal Degradation of the EWS-FLI1 Fusion Protein Is Regulated by a Single Lysine Residue.
Gierisch ME; Pfistner F; Lopez-Garcia LA; Harder L; Schäfer BW; Niggli FK
J Biol Chem; 2016 Dec; 291(52):26922-26933. PubMed ID: 27875302
[TBL] [Abstract][Full Text] [Related]
6. Targeting the epigenetic readers in Ewing sarcoma inhibits the oncogenic transcription factor EWS/Fli1.
Jacques C; Lamoureux F; Baud'huin M; Rodriguez Calleja L; Quillard T; Amiaud J; Tirode F; Rédini F; Bradner JE; Heymann D; Ory B
Oncotarget; 2016 Apr; 7(17):24125-40. PubMed ID: 27006472
[TBL] [Abstract][Full Text] [Related]
7. Genetically Engineered Mouse Model in Ewing Sarcoma.
Tanaka M; Nakamura T
Methods Mol Biol; 2021; 2226():183-189. PubMed ID: 33326102
[TBL] [Abstract][Full Text] [Related]
8. Molecular Approaches to Diagnosis in Ewing Sarcoma: RT-PCR.
Rodríguez-Martín C; Alonso J
Methods Mol Biol; 2021; 2226():85-103. PubMed ID: 33326095
[TBL] [Abstract][Full Text] [Related]
9. Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA.
Hayashi M; Chu D; Meyer CF; Llosa NJ; McCarty G; Morris CD; Levin AS; Wolinsky JP; Albert CM; Steppan DA; Park BH; Loeb DM
Cancer; 2016 Oct; 122(19):3015-23. PubMed ID: 27351911
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profile of ewing sarcoma cell lines differing in their EWS-FLI1 fusion type.
Bandrés E; Malumbres R; Escalada A; Cubedo E; González I; Honorato B; Zarate R; García-Foncillas J; de Alava E
J Pediatr Hematol Oncol; 2005 Oct; 27(10):537-42. PubMed ID: 16217257
[TBL] [Abstract][Full Text] [Related]
11. [Integrative molecular pathology of cancer].
Grünewald TGP
Pathologe; 2020 Dec; 41(Suppl 2):67-69. PubMed ID: 33263807
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation profiling distinguishes Ewing-like sarcoma with EWSR1-NFATc2 fusion from Ewing sarcoma.
Koelsche C; Kriegsmann M; Kommoss FKF; Stichel D; Kriegsmann K; Vokuhl C; Grünewald TGP; Romero-Pérez L; Kirchner T; de Alava E; Diaz-Martin J; Hartmann W; Baumhoer D; Antonescu CR; Szuhai K; Flucke U; Dirksen U; Pfister SM; Jones DTW; Mechtersheimer G; von Deimling A
J Cancer Res Clin Oncol; 2019 May; 145(5):1273-1281. PubMed ID: 30895378
[TBL] [Abstract][Full Text] [Related]
13. Prostatic carcinoma with neuroendocrine differentiation harboring the EWSR1-FEV fusion transcript in a man with the WRN G327X germline mutation: A new variant of prostatic carcinoma or a member of the Ewing sarcoma family of tumors?
Febres-Aldana CA; Krishnamurthy K; Delgado R; Kochiyil J; Poppiti R; Medina AM
Pathol Res Pract; 2020 Feb; 216(2):152758. PubMed ID: 31831298
[TBL] [Abstract][Full Text] [Related]
14. EWS-FLI1 and EWS-ERG gene fusions are associated with similar clinical phenotypes in Ewing's sarcoma.
Ginsberg JP; de Alava E; Ladanyi M; Wexler LH; Kovar H; Paulussen M; Zoubek A; Dockhorn-Dworniczak B; Juergens H; Wunder JS; Andrulis IL; Malik R; Sorensen PH; Womer RB; Barr FG
J Clin Oncol; 1999 Jun; 17(6):1809-14. PubMed ID: 10561219
[TBL] [Abstract][Full Text] [Related]
15. Ewing Sarcoma-Specific (Re)expression Models.
Knott MML; Cidre-Aranaz F
Methods Mol Biol; 2021; 2226():119-138. PubMed ID: 33326097
[TBL] [Abstract][Full Text] [Related]
16. MiR-708-5p is inversely associated with EWS/FLI1 Ewing sarcoma but does not represent a prognostic predictor.
Roberto GM; Vieira GM; Delsin LEA; Silva MO; Hakime RG; Engel EE; Scrideli CA; Tone LG; Brassesco MS
Cancer Genet; 2019 Jan; 230():21-27. PubMed ID: 30470587
[TBL] [Abstract][Full Text] [Related]
17. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
[TBL] [Abstract][Full Text] [Related]
18. Molecular confirmation of Ewing sarcoma.
Dagher R; Pham TA; Sorbara L; Kumar S; Long L; Bernstein D; Mackall C; Raffeld M; Tsokos M; Helman L
J Pediatr Hematol Oncol; 2001 May; 23(4):221-4. PubMed ID: 11846300
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous Ewing Sarcoma Presenting as a Second Primary Malignancy in a Child.
Daley J; Williams N; Salgado CM; Schultz C; Meade J; Ozolek J; Lindsey B; Bailey KM
J Pediatr Hematol Oncol; 2022 Nov; 44(8):486-488. PubMed ID: 35426856
[TBL] [Abstract][Full Text] [Related]
20. Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent.
Uren A; Toretsky JA
Future Oncol; 2005 Aug; 1(4):521-8. PubMed ID: 16556028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]